The Real-World Provider

Peptides in the Clinic: What Providers Need to Know Before Offering Peptide Therapy: Episode 14

Peptide therapy is one of the fastest-growing areas in clinical practice — and one of the most confusing when it comes to what's legal, what's evidence-based, and what actually belongs in your clinic. In this episode of The Real World Provider, Danni Owens, FNP-BC, breaks down the peptides every healthcare provider should know about in 2026: from healing peptides like BPC-157 and TB-500, to growth hormone secretagogues like ipamorelin and CJC-1295, to immune modulators, cognitive enhancers, longevity peptides, and more. This episode covers the 2026 FDA reclassification announcement, the difference between Category 1 and Category 2 peptides, what RFK Jr.'s announcement actually means for your practice, and the five things every provider needs to do before prescribing peptide therapy. If you're an NP, PA, or physician offering — or considering — peptide therapy in your clinic, this is your real-world guide. Peptides covered: BPC-157, TB-500, GHK-Cu, Ipamorelin, CJC-1295, Sermorelin, Thymosin Alpha-1, AOD-9604, Selank, Semax, KPV, MOTS-c, Epitalon, DSIP, and Kisspeptin-10.

Running a Weight Loss Clinic on GLP-1s: What Every Provider Needs to Know Right Now: Episode 13

Are you a provider running — or thinking about starting — a weight loss clinic using GLP-1 medications? In this episode of The Real World Provider, Danni Owens, FNP-BC, breaks down everything healthcare providers need to know about semaglutide and tirzepatide in 2026. From the FDA's oral Wegovy approval to the compounding pharmacy legal battles, prescribing authority by state, clinical protocols, cash-pay pricing models, and where the GLP-1 market is heading — this is the real-world guide to building a sustainable weight loss practice with GLP-1 receptor agonists. Whether you're an NP, PA, or MD looking to add GLP-1 prescribing to your clinic, or you're already offering weight management services and want to stay ahead of the regulatory changes, this episode covers it all. Topics include: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), 503A vs. 503B compounding pharmacies, FDA shortage list updates, patient selection criteria, titration protocols, side effect management, cash-pay clinic models, oral GLP-1 medications, insurance coverage trends, and how to compete with telehealth and retail clinics.

When Staff Betray You: Internal Threats to Your License: Episode 11

Let me start with something that most providers do not want to hear. Some of the biggest threats to your license… Are not patients. They’re not competitors. They’re not even investigators. Sometimes the biggest threat to your license… Is sitting in the chair at your front desk. Or drawing blood in your lab room. Or texting your patients from the clinic phone. And I say this with complete respect for good staff — because great staff are priceless.

Documentation That Defends You in Court and at the Board: Episode 10

Let me say something that may completely shift how you chart starting today. Your documentation is not for the patient. It is not for billing. It is not for insurance. It is not for your memory. Your documentation is for the worst day of your career. It is for the attorney reading it five years from now. It is for the Board investigator who has never met you. It is for the expert witness who is trying to decide if you were reckless… or reasonable. Documentation is not a task. It is a defense strategy. And today, we’re talking about how to document in a way that protects you in court and at the Board. Because minimal charting is comfortable… But comprehensive charting is protective.

Toxic Competition and Reporting Culture in Healthcare: Episode 9

There is something happening in healthcare that nobody wants to say out loud. Some investigations… Don’t start with patient harm. They start with competition. They start with jealousy. They start with someone watching your growth and deciding they don’t like it. And instead of improving their own clinic… They file a complaint. Welcome to the reporting culture of modern healthcare. Where your success can become someone else’s motive. Today we’re talking about toxic competition — how it shows up, how it escalates, and how to protect yourself without becoming paranoid. Because we’re not operating in fear. We’re operating in awareness.